213 related articles for article (PubMed ID: 30427821)
1. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 2: Strategies to Minimize Adverse Outcomes From Unintended DDIs.
Preskorn SH
J Psychiatr Pract; 2018 Sep; 24(5):341-347. PubMed ID: 30427821
[TBL] [Abstract][Full Text] [Related]
2. Drug-drug Interactions in Psychiatric Practice, Part 4: Classification of Neuropsychiatric Medications Based on Their Principal Mechanisms of Action (With Updated Neuroscience-based Nomenclature).
Preskorn SH; Germann A
J Psychiatr Pract; 2019 Mar; 25(2):118-127. PubMed ID: 30849059
[TBL] [Abstract][Full Text] [Related]
3. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 8: Relative Receptor Binding Affinity as a Way of Understanding the Differential Pharmacology of Currently Available Antidepressants.
Preskorn SH
J Psychiatr Pract; 2020 Jan; 26(1):46-51. PubMed ID: 31913969
[TBL] [Abstract][Full Text] [Related]
4. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 9: Interactions Mediated by Drug-metabolizing Cytochrome P450 Enzymes.
Preskorn SH
J Psychiatr Pract; 2020 Mar; 26(2):126-134. PubMed ID: 32134885
[TBL] [Abstract][Full Text] [Related]
5. Drug-drug Interactions in Psychiatric Practice, Part 1: Reasons, Importance, and Strategies to Avoid and Recognize Them.
Preskorn SH
J Psychiatr Pract; 2018 Jul; 24(4):261-268. PubMed ID: 30427809
[TBL] [Abstract][Full Text] [Related]
6. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 7: Relative Receptor Binding Affinity as a Way of Understanding the Differential Pharmacology of Currently Available Antipsychotics.
Preskorn SH
J Psychiatr Pract; 2019 Nov; 25(6):461-465. PubMed ID: 31821222
[TBL] [Abstract][Full Text] [Related]
7. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 6: Pharmacodynamic Considerations.
Preskorn SH
J Psychiatr Pract; 2019 Jul; 25(4):290-297. PubMed ID: 31291209
[TBL] [Abstract][Full Text] [Related]
8. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 5: Major Types of Pharmacodynamic DDIs Based on Mechanism of Action (With Updated Neuroscience-based Nomenclature).
Preskorn SH; Germann A
J Psychiatr Pract; 2019 May; 25(3):206-211. PubMed ID: 31083033
[TBL] [Abstract][Full Text] [Related]
9. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 3: Pharmacokinetic Considerations.
Preskorn SH
J Psychiatr Pract; 2019 Jan; 25(1):34-40. PubMed ID: 30633730
[TBL] [Abstract][Full Text] [Related]
10. Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.
Ko Y; Malone DC; Skrepnek GH; Armstrong EP; Murphy JE; Abarca J; Rehfeld RA; Reel SJ; Woosley RL
Drug Saf; 2008; 31(6):525-36. PubMed ID: 18484786
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacists' interventions conducted by hospital pharmacists on psychotropic drugs pharmacotherapy].
Parent G; Rose FX; Bedouch P; Conort O; Charpiat B; Juste M; Roubille R; Allenet B
Encephale; 2015 Sep; 41(4):339-45. PubMed ID: 25523124
[TBL] [Abstract][Full Text] [Related]
12. Consistency of psychotropic drug-drug interactions listed in drug monographs.
Liu X; Hatton RC; Zhu Y; Hincapie-Castillo JM; Bussing R; Barnicoat M; Winterstein AG
J Am Pharm Assoc (2003); 2017; 57(6):698-703.e2. PubMed ID: 28844584
[TBL] [Abstract][Full Text] [Related]
13. Why Are Patients With COVID-19 at Risk for Drug-Drug Interactions?
Preskorn SH; Quadri S
J Psychiatr Pract; 2020 Nov; 26(6):485-492. PubMed ID: 33275385
[TBL] [Abstract][Full Text] [Related]
14. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
15. A Practical Approach to Avoiding Cardiovascular Adverse Effects of Psychoactive Medications.
Brouillette J; Nattel S
Can J Cardiol; 2017 Dec; 33(12):1577-1586. PubMed ID: 29173600
[TBL] [Abstract][Full Text] [Related]
16. Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients.
Wang Y; Bahar MA; Jansen AME; Kocks JWH; Alffenaar JC; Hak E; Wilffert B; Borgsteede SD
J Antimicrob Chemother; 2019 Oct; 74(10):2848-2864. PubMed ID: 31127283
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
18. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
Somogyi-Végh A; Ludányi Z; Erdős Á; Botz L
BMC Pharmacol Toxicol; 2019 May; 20(1):36. PubMed ID: 31151485
[TBL] [Abstract][Full Text] [Related]
19. Assessing patients' information needs regarding drug-drug interactions.
Mutebi A; Warholak TL; Hines LE; Plummer R; Malone DC
J Am Pharm Assoc (2003); 2013; 53(1):39-45. PubMed ID: 23636154
[TBL] [Abstract][Full Text] [Related]
20. A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study.
Pasina L; Marengoni A; Ghibelli S; Suardi F; Djade CD; Nobili A; Franchi C; Guerrini G
Drugs Aging; 2016 Feb; 33(2):143-9. PubMed ID: 26689398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
